Atherogenic index as an associative marker for coronary artery disease
Authors:
- Dilip JohnyDJDilip Johny
- Adesh KumarAKAdesh Kumar
- 9 January 2026
- journal article
- research article
- Published by Springer Nature in Herz
- Vol. 51 (5) , 1-8
Abstract
Background Coronary artery disease (CAD) is a significant global health burden, warranting pragmatic, low-cost biomarkers for effective risk stratification. The atherogenic index of plasma (AIP), calculated as log(TG/HDL-C), is a lipid-derived indicator of cardiometabolic risk. We evaluated AIP as an associative marker for CAD and compared its diagnostic performance with commonly used biomarkers. Methods In a hospital-based, angiography-confirmed case–control cohort (n = 340; 211 cases, 129 controls), we assessed AIP alongside uric acid, creatinine, neutrophil-to-lymphocyte ratio (NLR), TG/HDL‑C, HbA1c, and ejection fraction. Group characteristics were summarized using descriptive statistics, chi-square tests, and ANOVA. Associations with CAD were examined using multivariable logistic regression adjusted for age, sex, body mass index, diabetes, hypertension, smoking status, and statin use. Discriminative performance was evaluated via receiver operating characteristic (ROC) analysis, with pairwise comparisons conducted using DeLong’s test. Results Values of AIP (OR 1.42, 95% CI 1.18–1.69; p = 0.012), uric acid (OR 1.20, 95% CI 1.02–1.42; p = 0.032), and creatinine (OR 1.69, 95% CI 1.03–2.76; p = 0.038) were independently associated with CAD. HbA1c, TG/HDL‑C, NLR, and ejection fraction were not significantly associated in multivariable models. Values of AIP increased with greater angiographic severity. In ROC analysis, AIP showed superior discriminatory ability to uric acid, creatinine, NLR, and HbA1c (all p < 0.05, DeLong test), and performed comparably to TG/HDL‑C, consistent with AIP being its log transformation. Conclusion Readily available AIP offers incremental prognostic value in symptomatic patients with suspected CAD. These findings are hypothesis-generating; thus, thresholds should be interpreted cautiously pending prospective, multicenter studies.Keywords
This publication has 17 references indexed in Scilit:
- Atherogenic index of plasma as predictors for metabolic syndrome, hypertension and diabetes mellitus in Taiwan citizens: a 9-year longitudinal studyScientific Reports, 2021
- The atherogenic index of plasma and its impact on recanalization of chronic total occlusionCardiology Journal, 2020
- Atherogenic Index of Plasma Is an Independent Risk Factor for Coronary Artery Disease and a Higher SYNTAX ScoreAngiology, 2020
- Assessment of Biventricular Function by Three-Dimensional Speckle Tracking Echocardiography in Adolescents and Young Adults with Human Immunodeficiency Virus Infection: A Pilot StudyCardiology, 2019
- Association of PET-measured myocardial flow reserve with echocardiography-estimated pulmonary artery systolic pressure in patients with hypertrophic cardiomyopathyPLOS ONE, 2019
- Rationale and design of a multicenter randomized study for evaluating vascular function under uric acid control using the xanthine oxidase inhibitor, febuxostat: the PRIZE studyCardiovascular Diabetology, 2016
- Oxidative stress: New insights on the association of non-alcoholic fatty liver disease and atherosclerosisWorld Journal of Hepatology, 2015
- Neutrophil/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiographyAtherosclerosis, 2012
- Comparison of Novel Risk Markers for Improvement in Cardiovascular Risk Assessment in Intermediate-Risk IndividualsJAMA, 2012
- Effects of Eprosartan on Serum Metabolic Parameters in Patients with Essential HypertensionThe Open Cardiovascular Medicine Journal, 2007